355 related articles for article (PubMed ID: 2565778)
1. Restriction fragment length polymorphism of HLA and non-HLA genes in DR3/4 heterozygous Danish insulin-dependent diabetic patients and healthy individuals: reassessment of the influence of alpha DX and insulin-linked polymorphic loci, and new splits of DQw3 haplotypes.
Zerbib A; Mølvig J; Thomsen M; Coppin H; Cambon-Thomsen A; Sommer E; Nerup J; De Preval C
Dis Markers; 1989; 7(1):27-41. PubMed ID: 2565778
[TBL] [Abstract][Full Text] [Related]
2. HLA DR4-DQw3.1 and 3.2 haplotypes among insulin-dependent diabetics and their unaffected sibs in the GAW5 data.
Gogolin KJ; Spielman RS
Genet Epidemiol; 1989; 6(1):113-6. PubMed ID: 2567253
[TBL] [Abstract][Full Text] [Related]
3. Insulin-dependent diabetes mellitus: HLA-DR and -DQ genotyping in three ethnic groups.
Kohonen-Corish MR; Serjeantson SW; Lee HK; Zimmet P
Dis Markers; 1987 Sep; 5(3):153-64. PubMed ID: 2901933
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin-dependent diabetes mellitus with HLA-DQ.
Michelsen B; Lernmark A
J Clin Invest; 1987 Apr; 79(4):1144-52. PubMed ID: 2881947
[TBL] [Abstract][Full Text] [Related]
5. New HLA DNA polymorphisms associated with rheumatoid arthritis.
Cutbush SD; Ollier W; Awad J; Currey HL; Festenstein H
Dis Markers; 1986 Jun; 4(1-2):173-83. PubMed ID: 2898314
[TBL] [Abstract][Full Text] [Related]
6. DQ beta restriction fragment length polymorphism and its relationship to insulin dependent diabetes mellitus.
Sachs JA; Cassell PG; Festenstein H; Awad J; Hitman GA
Dis Markers; 1987 Dec; 5(4):199-206. PubMed ID: 2901934
[TBL] [Abstract][Full Text] [Related]
7. Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes.
Liu CP; Bach FH; Wu SK
J Immunol; 1988 May; 140(10):3631-9. PubMed ID: 3129499
[TBL] [Abstract][Full Text] [Related]
8. HLA-DR and -DQ DNA genotyping in insulin-dependent diabetes patients in South India.
Serjeantson SW; Ranford PR; Kirk RL; Kohonen-Corish MR; Mohan V; Ramachandran A; Snehalatha C; Viswanathan M
Dis Markers; 1987 Jun; 5(2):101-8. PubMed ID: 2901931
[TBL] [Abstract][Full Text] [Related]
9. DR beta Taq I restriction fragment length polymorphism (RFLP) associated with insulin dependent diabetes mellitus (IDDM).
Hodge TW; Barger BO; Acton RT
Dis Markers; 1987 Jun; 5(2):109-17. PubMed ID: 2901932
[TBL] [Abstract][Full Text] [Related]
10. Restriction fragment length polymorphism analysis of HLA haplotypes in families with type I diabetes mellitus.
Badenhoop K; Schwarz G; Bingley P; Lewis V; Drummond V; Gale EA; Bottazzo GF
Tissue Antigens; 1990 Jan; 35(1):32-9. PubMed ID: 1968292
[TBL] [Abstract][Full Text] [Related]
11. Extended HLA haplotypes in multiplex families with insulin dependent diabetes mellitus in Tunisian population: HLA serological typing and RFLP analysis.
Jenhani F; Bardi R; Ayed K; Chammakhi S; Jeddi M; Labonne MP; Gebuhrer L; Betuel H
Dis Markers; 1990; 8(6):327-31. PubMed ID: 1983195
[TBL] [Abstract][Full Text] [Related]
12. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus.
Pociot F; Briant L; Jongeneel CV; Mölvig J; Worsaae H; Abbal M; Thomsen M; Nerup J; Cambon-Thomsen A
Eur J Immunol; 1993 Jan; 23(1):224-31. PubMed ID: 8093442
[TBL] [Abstract][Full Text] [Related]
13. HLA class II alpha chain gene polymorphisms in patients with insulin-dependent diabetes mellitus, dermatitis herpetiformis, and celiac disease.
Hitman GA; Niven MJ; Festenstein H; Cassell PG; Awad J; Walker-Smith J; Leonard JN; Fry L; Ciclitira P; Kumar P
J Clin Invest; 1987 Feb; 79(2):609-15. PubMed ID: 3805283
[TBL] [Abstract][Full Text] [Related]
14. HLA DQ beta 3.2 identifies subtypes of DR4+ haplotypes permissive for IDDM.
Robinson DM; Holbeck S; Palmer J; Nepom GT
Genet Epidemiol; 1989; 6(1):149-54. PubMed ID: 2567255
[TBL] [Abstract][Full Text] [Related]
15. HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis.
Haegert DG; Michaud M; Schwab C; Tansey C; Décary F; Francis G
J Neurosci Res; 1989 May; 23(1):46-54. PubMed ID: 2568496
[TBL] [Abstract][Full Text] [Related]
16. Restriction fragment polymorphisms of the HLA-DR, HLA-DQ, and insulin gene regions in IDDM: the GAW5 data.
Cox NJ; Gogolin KJ; Horvath VJ; Barker DF; Wright E; Tran T; Skolnick MH; Boehm BO; Fehsel K; Bertrams J
Genet Epidemiol; 1989; 6(1):21-6. PubMed ID: 2567259
[TBL] [Abstract][Full Text] [Related]
17. Application of synthetic oligonucleotides to detect DQ beta genes transmission within insulin-dependent diabetes families.
Toyoda H; Onohara-Toyoda M; Krull J; Vadheim CM; Bickal JC; Riley WJ; MacLaren NK; Itakura K; Rotter JI
Dis Markers; 1989; 7(4):215-28. PubMed ID: 2573447
[TBL] [Abstract][Full Text] [Related]
18. DNA polymorphism of the class II genes in DR4 cells.
So A; Bodmer J
Dis Markers; 1986 Jun; 4(1-2):165-72. PubMed ID: 2898313
[TBL] [Abstract][Full Text] [Related]
19. HLA and insulin gene associations with IDDM.
Thomson G; Robinson WP; Kuhner MK; Joe S; Klitz W
Genet Epidemiol; 1989; 6(1):155-60. PubMed ID: 2567257
[TBL] [Abstract][Full Text] [Related]
20. Immunogenetic markers for autoimmune diseases of the endocrine system.
Badenhoop K
Klin Wochenschr; 1990; 68 Suppl 21():10-4. PubMed ID: 1973965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]